482 related articles for article (PubMed ID: 8148215)
1. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
Vainionpää LK; Mikkonen K; Rättyä J; Knip M; Pakarinen AJ; Myllylä VV; Isojärvi JI
Epilepsia; 2004 Mar; 45(3):197-203. PubMed ID: 15009219
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate.
Hirfanoglu T; Serdaroglu A; Camurdan O; Cansu A; Bideci A; Cinaz P; Gucuyener K
Pediatr Int; 2007 Dec; 49(6):822-6. PubMed ID: 18045279
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
[TBL] [Abstract][Full Text] [Related]
7. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy.
Rättyä J; Turkka J; Pakarinen AJ; Knip M; Kotila MA; Lukkarinen O; Myllylä VV; Isojärvi JI
Neurology; 2001 Jan; 56(1):31-6. PubMed ID: 11148232
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oxcarbazepine and carbamazepine: a double-blind study.
Reinikainen KJ; Keränen T; Halonen T; Komulainen H; Riekkinen PJ
Epilepsy Res; 1987 Sep; 1(5):284-9. PubMed ID: 3504404
[TBL] [Abstract][Full Text] [Related]
10. Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine.
Battino D; Croci D; Granata T; Bernardi G; Monza G
Ther Drug Monit; 1992 Oct; 14(5):376-9. PubMed ID: 1448844
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics and indications of oxcarbazepine].
Herranz JL; Argumosa A
Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
Ahmad A; Garnett WR
Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
[TBL] [Abstract][Full Text] [Related]
14. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
Christe W; Krämer G; Vigonius U; Pohlmann H; Steinhoff BJ; Brodie MJ; Moore A
Epilepsy Res; 1997 Mar; 26(3):451-60. PubMed ID: 9127726
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine.
Tecoma ES
Epilepsia; 1999; 40 Suppl 5():S37-46. PubMed ID: 10530693
[TBL] [Abstract][Full Text] [Related]
16. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
Schmidt D; Elger CE
Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
[TBL] [Abstract][Full Text] [Related]
17. Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth-pursuit eye movements.
Zaccara G; Gangemi PF; Messori A; Parigi A; Massi S; Valenza T; Monza GC
Acta Neurol Scand; 1992 Jun; 85(6):425-9. PubMed ID: 1642114
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
19. Drug interaction profile of topiramate.
Bourgeois BF
Epilepsia; 1996; 37 Suppl 2():S14-S17. PubMed ID: 8641241
[TBL] [Abstract][Full Text] [Related]
20. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy.
Guerreiro MM; Vigonius U; Pohlmann H; de Manreza ML; Fejerman N; Antoniuk SA; Moore A
Epilepsy Res; 1997 Jun; 27(3):205-13. PubMed ID: 9237055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
